These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Revisions to the requirements applicable to blood, blood components, and source plasma; confirmation in part and technical amendment. Food and Drug Administration, HHS. Direct final rule; confirmation in part and technical amendment. Fed Regist; 2001 Jan 10; 66(7):1834-7. PubMed ID: 11503754 [Abstract] [Full Text] [Related]
7. Revisions to the requirements applicable to blood, blood components and source plasma; confirmation of effective date and technical amendment. Direct final rule; confirmation of effective date and technical amendment. Food and Drug Administration, HHS. Fed Regist; 2008 Feb 08; 73(27):7463-4. PubMed ID: 18389917 [Abstract] [Full Text] [Related]
8. Revisions to the requirements applicable to blood, blood components, and source plasma. Final rule. Food and Drug Administration, HHS. Fed Regist; 2001 Aug 06; 66(151):40886-90. PubMed ID: 11732557 [Abstract] [Full Text] [Related]
12. Revisions to the general safety requirements for biological products--FD. Direct final rule. Fed Regist; 1998 Apr 20; 63(75):19399-403. PubMed ID: 10178869 [Abstract] [Full Text] [Related]
13. Blood vessels recovered with organs and intended for use in organ transplantation. Direct final rule. Food and Drug Administration, Health Resources and Services Administration, (HHS). Fed Regist; 2006 May 12; 71(92):27606-10. PubMed ID: 16696153 [Abstract] [Full Text] [Related]
14. Amendment to examination and investigation sample requirements--FDA. Direct final rule. Fed Regist; 1998 Sep 25; 63(186):51297-9. PubMed ID: 10185810 [Abstract] [Full Text] [Related]
15. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human); confirmation in part and technical amendment. Food and Drug Administration, HHS. Direct final rule; confirmation in part and technical amendment. Fed Regist; 2000 Mar 14; 65(50):13678-9. PubMed ID: 11010647 [Abstract] [Full Text] [Related]
16. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 Aug 28; 65(167):52016-8. PubMed ID: 11067735 [Abstract] [Full Text] [Related]
17. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule. Fed Regist; 1996 Sep 09; 61(175):47413-23. PubMed ID: 10160337 [Abstract] [Full Text] [Related]
18. Medical devices; medical device reporting; baseline reports. Direct final rule. Food and Drug Administration, HHS. Fed Regist; 2008 Jun 13; 73(115):33692-5. PubMed ID: 18677824 [Abstract] [Full Text] [Related]
19. Medical devices; hearing aids; technical data amendments. Direct final rule. Food and Drug Administration, HHS. Fed Regist; 2008 Jun 02; 73(106):31358-60. PubMed ID: 18677822 [Abstract] [Full Text] [Related]
20. Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule. Food and Drug Administration, HHS. Fed Regist; 2001 Jun 11; 66(112):31146-65. PubMed ID: 11725786 [Abstract] [Full Text] [Related] Page: [Next] [New Search]